Sporadic colorectal cancer (CRC) is a major health concern worldwide. Epidemiologic evidence suggests a polygenic predisposition to CRC, but the genes responsible remain unknown. Here, we performed genome-wide scanning of male (ACI x Wistar-Furth)F2 (AWF2) rats to map susceptibility genes influencing the evolution of early colorectal lesions to adenocarcinoma following dimethylhydrazine administration. Phenotypic analysis revealed higher incidence/multiplicity and lower size of adenomas in ACI and AWF1 than WF rats, and higher incidence/multiplicity of poorly differentiated adenocarcinomas in WF than ACI rats, with intermediate values in AWF1 rats. Linkage analysis of 138 AWF2 rats identified 3 loci on chromosomes 4, 15, and 18, in significant linkage with lesion multiplicity that were identified as rat Colon cancer resistance (rCcr) 1, rCcr2, and rCcr3, respectively. Seven other loci on chromosomes 5, 6, 15, 17, 18, and 20, were in suggestive linkage with adenoma/adenocarcinoma multiplicity/surface area. Six of them were identified as rCcr4-9,and a locus on chromosome 5, was identified as a susceptibility locus, rCcs1. Significant interactions between rCcr3 and rCcr6, cRcr6 and rCcr8, and rCcr5 and rCcr9, and 4 novel epistatic loci controlling multiplicity/size of colorectal lesions were discovered. Apc, located at rCcr3, did not show functional promoter polymorphisms.
Introduction
Colorectal cancer (CRC) is a common disease, both in men and women, worldwide (1) . Environmental risk factors include diet and lifestyle (2) . Sporadic, inherited, and familial CRC have been identified (2, 3) . Inherited syndromes, occurring in less than 10% of patients, include familial adenomatous polyposis (FAP) and hamartomatous polyposis, hereditary non-polyposis colorectal cancer (Lynch syndrome), and cancer family syndrome (Lynch-like syndrome) (4).
Sporadic disease accounts for approximately 70% of colorectal cancers. In some families, CRC develops too frequently to be considered sporadic, but not in a pattern consistent with an inherited syndrome (1) . This envisages a role of low-penetrance predisposing genes, each partly contributing to CRC predisposition. Various genes, including APC, TGF-βR1, H-RAS1, MTHFR, BLM, HFE, GSTT1 and CCND1 have been found to be involved in the pathogenesis of sporadic CRC (2, 5) . However, their relationship with polygenic predisposition to CRC is unclear.
Mapping of low penetrance susceptibility genes is difficult in the human population due to its heterogeneity and the interactions between genes and environmental factors. Consequently, experimental models are currently used to map susceptibility-related genes in quantitative trait loci (QTLs). Various studies indicate that the genetic variants controlling susceptibility to complex diseases, including cancer, often map to orthologous regions of rodent and human genomes, and various diseases are caused by polymorphism of equivalent rodent and human genes (6, 7) . Thus, preliminary mapping of susceptibility-related genes in rodent models allows defining the genetic model, identifying candidate modifier genes, and evaluating their phenotypic and molecular effects. This information is essential to attempt gene cloning and identifying the genetic mechanisms of the human disease.
Researches on mouse have led to the identification of Colon cancer susceptibility (Ccs) loci 1 and 2 on chromosomes 12 and 3, respectively, affecting the susceptibility to 1,2-dimethylhydrazine (DMH)-induced CRC (8, 9) . Various congenic mice strains exhibit different patterns of susceptibility to aberrant crypt foci (ACFs) and colon adenomas, indicating the involvement of different subsets of genes (10) . The inheritance of the susceptible parental alleles Scc1 or Scc2 (Susceptibility to colon cancer), on chromosome 2, and the resistance allele Scc3, on chromosome 1, affects the susceptibility to DMH-induced CRC (11, 12) . Scc4 (chromosome 17) and Scc5 (Chromosome 18), not displaying individual phenotypic effects, show reciprocal interactions (12) . Interestingly, Ptprj gene, located at Scc1, encoding a receptor-type protein tyrosine phosphatase, is a candidate modifier of colon carcinogenesis in mice (13) , and is frequently deleted in human cancers, including CRC.
Researches on the genetic susceptibility of rats to CRC are scanty. No correlation was found between Apc and Pla2g2a genes polymorphisms and the susceptibility to aberrant crypt foci (ACFs) development in rats treated with 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; 14).
On the other hand, a locus on chromosome 16, in significant linkage with ACF formation, was identified (15) .
Colorectal carcinogenesis is a multistage process with a well-defined sequence of events from aberrant crypt proliferation, to benign adenoma, well differentiated (WD) adenocarcinoma and finally to poorly differentiated (PD) adenocarcinoma. Available data do not allow identifying the stages of colorectal carcinogenesis controlled by the loci discovered so far. The analysis of the development of ACFs, commonly considered putative precancerous lesions (16) , may give insights on the genes controlling the initiation stage in rats. Only a relatively small subset of ACFs undergo further evolution to PD adenocarcinoma, and it is not clear whether the locus discovered on chromosome 16 (15) influences the evolution of initiated cells to cancer. To determine the map location of tumor susceptibility genes influencing the evolution of early colorectal lesions to PD adenocarcinoma and further enlighten the pathogenesis of sporadic CRC, we performed a genome-wide scanning on a group of (ACI x WistarFurth)F2 (AWF2) rats, in which the development of adenomas and adenocarcinomas has been induced with DMH. New QTLs and epistatic loci, in linkage with the propensity of colorectal adenomas to progress to malignancy have been discovered. Also, we show that at least some of the loci identified affect the Wnt/β-catenin pathway in premalignant and malignant colorectal lesions of susceptible rats.
Materials and Methods

Animals
Twenty ACI (A), Wistar-Furth (W; Charles-River Italia, Calco, Italy), (A x W)F1 (AWF1), and 138 AWF2 rats (180-200 g) were fed a standard diet (type 48, Piccioni, Gessate, Italy) and tap water ad libitum. They were housed individually in a room with constant temperature (22 o C) and humidity (55%) and with a 12 h light (6 a.m.-6 p.m.)/dark cycle. Study protocols were in compliance with our institution's guidelines for the use of laboratory animals.
Phenotyping
Colorectal adenomas, WD and PD adenocarcinomas were induced by injecting s.c. DMH (20 mg/kg body weigh) weekly for 26 weeks. Control (untreated) and DMH-treated rats were killed 32 weeks after initiation, by bleeding through thoracic aorta under ether anesthesia. Colorectal lesions present in the entire length of colon and rectum appeared as spherical or ovoid lesions with a velvety smooth or slightly bossy appearance. Lesions were counted and a caliper was used to determine their maximum and minimum diameter. Lesion thickness could not be accurately evaluated due to the sessile feature of the majority of lesions, and the surface area was taken as a measure of the lesion size. For microscopic evaluation, small pieces of isolated lesions were processed for hematoxylin/eosin staining and β-catenin immunohistochemistry as published (17) , using an anti-β-Catenin monoclonal antibody (Transduction Laboratories, Lexington, KY), whose specificity has been previously tested (18) .
Genotyping
Genomic DNA from spleens of intercross rats was extracted from isolated nuclei and purified (19 (19) .
Nucleotide sequence analysis
Primers were designed to amplify rat β-Catenin exon 2 (GenBank Acc. # AF397179), Apc promoter (GenBank Acc. # AB071148), and all Apc exons (GenBank Acc. # NM012499). DNA from WF, ACI and AWF1 rats was amplified by PCR as published (21) . Aliquots of the PCR products were purified by the "High Pure PCR Product Purification Kit" (Roche Diagnostics, Mannheim, Germany), sequenced using an Alfexpress Automated Sequencer (GE Healthcare, Milano, Italy), and aligned and compared to identify polymorphisms. Gene data base searches were performed at the National Center for Biotechnology Information (NCBI).
Quantitative RT-PCR
Primers for Apc, c-myc, and RNR-18 were chosen using the "Assays-on-Demand TM Products" (Applied Biosystems, Foster City, CA). PCR reactions were performed with 75-300 ng of cDNA, using the ABI Prism 7000 Sequence Detection System and the Taq Man Universal PCR Master Mix (Applied Biosystems) as published (17) . Quantitative values were calculated using the PE Biosystems Analysis software.
Immunoblot analysis
Tissue samples were homogenized in lysis buffer and protein concentrations were determined as published (17) . Whole cell lysates (350 µg) from normal and neoplastic colorectal mucosa tissues were processed as reported (17) . Immunoprecipitations were carried out with 6 µg of rabbit polyclonal anti-antibodies anti-β-Catenin, Axin2, phosphorylated β-Catenin (Serine 33), and β-Actin (SC-7199, SC-8570; SC-22192, and SC-1615, respectively; Santa Cruz Biotechnology, Santa Cruz, CA). Immunoprecipitated proteins were subjected to Western blotting and membranes were probed with HRP-secondary antibodies. For Western blot analysis, 100 μg of proteins were extracted, denatured, separated by SDS-PAGE, and 6 transferred onto nitrocellulose membranes by electroblotting. Membranes were probed with goat polyclonal antibodies anti-Apc (SC-896, cterminus epitope), followed by incubation with HRP-secondary antibody, and revealed with Luminol Reagent. Densities of the protein bands were normalized to β-actin levels and calculated by ImageQuant Software.
Statistical analysis
Linkage maps were constructed using the MAPMAKER/EXP 3.0 program (22) . The associations of tumor susceptibility (low-responder vs.
high-responder, as defined on the basis of multiplicity and surface area of lesions in parental strains) with alleles of rat microsatellite markers were evaluated by LOD score. Threshold LOD score values at 2.8 and 4.3 were considered for "suggestive" and "significant" linkage, respectively (23) .
The proportion of total intercross variability explained by the association between the marker and the trait (R 2 ) was taken as an index of the importance of each locus. QTL analysis was carried out using parametric or non-parametric methods with MAPMAKER/QTL 1.1 (24) . The "additive and dominant" method of MAPMAKER/QTL and ANOVA (SAS Institute Inc., Cary, NC) procedures were used to confirm QTL analysis and evaluate the allelic contribution to the phenotypes. Furthermore, genomewide significance thresholds were established for each phenotype by 1000 permutation replicates by using the maximum likelihood method via an EM algorithm as implemented in the R/qtl mapping software (25) .
Empirical 5% significant thresholds were used. Potential interactions between genetic loci were evaluated by ANOVA, and P values were corrected for multiple comparisons (22) . Differences between parental strains and between homozygous and heterozygous intercross rats for phenotypic parameters were analyzed by ANOVA and multiple comparisons were made by the Tuckey-Kramer (TK) test using GraphPad InStat 3 (www.graphpad.com).
Results
Inheritance of the susceptibility to colorectal carcinogenesis
WF rats are highly susceptible to CRC, which develops spontaneously in 38% of male rats at 6 months of age (26). ACI rats are phylogenetically distant from WF rats (27) , and show resistance to the development of ACFs induced by PhIP (15) .
Food intake and body weight did not show any interstrain difference throughout the experiment (data not shown). In all strains examined, tubular adenomas with columnar darkly stained dysplastic epithelium were detected, whereas villous adenomas were only rarely found. WD adenocarcinomas exhibited irregular glandular pattern with little evidence of mucous secretion and hyperchromic epithelial cells showing irregular, prominent nuclei. PD adenocarcinomas displayed low tendency to form glandular patterns, cell pleomorphism, large irregular nuclei and tendency to invade the submucosa.
We tested the AWF1 progeny and parental strains for the susceptibility to DMH-induced colorectal tumors. As reported in Table 1 , WF rats exhibited a higher incidence and multiplicity of PD adenocarcinomas, and a lower incidence and multiplicity of adenomas and WD adenocarcinomas than ACI rats (although the differences regarding WD adenocarcinomas incidence and multiplicity did not reach significance threshold). This suggests the resistance of ACI rats to the progression of benign lesions to more advanced lesions, which was further substantiated by the relatively small surface area of ACI rat lesions, when compared to those of WF rats. In AWF1 rats, the pattern of colorectal adenoma development was similar to that of ACI rats, whereas WD and PD adenocarcinomas development resembled that of WF rats, excepting a lower surface area of the lesions.
Collectively, these findings suggest the existence of an intermediate susceptibility of AWF1 rats to the progression of benign lesions to WD and PD adenocarcinomas. As expected, the multiplicities and mean areas of adenomas, WD and PD adenocarcinomas of AWF2 rats were in the range of those found in parental strains (data not shown).
Linkage mapping of loci affecting the multiplicity and size of colorectal lesions
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The multiplicity of lesions was normally distributed, whereas surface area values were not normally distributed in 138 AWF2 rats. Therefore, to obtain an improved normality (28), QTL analysis was performed using a parametric method for multiplicity of lesions, and a nonparametric method for surface area. This analysis identified three QTLs in significant linkage with phenotypic parameters on chromosomes 4, 15, and 18 ( Figure 1 ).
The QTL on chromosome 4 exhibited a LOD score value of 4.3, in linkage with the surface area of adenomas. The QTL on chromosome 15 was in linkage with the multiplicity of total colorectal lesions (adenomas plus WD and PD adenocarcinomas) and showed a LOD score peak of 6.57, at 12 cM. LOD score was 4.3 when only PD adenocarcinoma multiplicity was considered. It should be noted that this QTL has been identified by using microsatellite markers relatively far from the QTL peak, and reciprocally distant 23.7 cM, a distance which is analyzed by MapMaker/QTL. In addition, ANOVA gave still significant p values for these markers (Table 2) , although the degree of significance was not high due to the distance of the markers from the QTL peak. This situation makes us confident of the existence of this QTL, although not completely excluding the possibility of an artefact. Moreover, a LOD score peak of 2.9, suggestive of genetic linkage with PD adenocarcinoma multiplicity, was present on chromosome 15
at 63.8 cM. A significant QTL was identified on chromosome 18, with LOD score peaks of 4.3 and 5.02, at 0 cM for PD adenocarcinoma multiplicity and surface area, respectively. Another LOD score peak of 3.1 was found on the same chromosome at 19.5 cM, in suggestive linkage with PD adenocarcinoma multiplicity. The presence of the QTLs on chromosomes 4, 15, and 18 was confirmed by the EM algorithm, which showed LOD sore peaks equivalent to those calculated via MapMaker/QTL, and higher than the LOD thresholds calculated by permutation analysis, for each phenotype, for empirical 5% significance (Table 2) .
Linkage analysis also showed other loci on chromosomes 5, 6, 17, and 20, with LOD score peak values suggestive of genetic linkage with multiplicity and/or average area of the lesions. The suggestivity of these QTLs was confirmed by the calculation of RT/qtl values, for each phenotype, lower than the 5% significance threshold (Table 2) . Nevertheless, all of these R/qtl values were higher than a 10% significance threshold (not shown).
On the basis of statistical considerations suggestive linkage may be wrong (23) . Thus, we analyzed by ANOVA these loci together with the significant ones, to evaluate whether the phenotypic features of the lesions in AWF2 rats are accounted for by the presence of susceptibility/resistance genes in the QTLs with suggestive linkage. We also analyzed the allelic distribution pattern in homozygous and heterozygous progeny to identify the contribution of parental strains to the phenotypic behavior of F2s. The results in Table 2 show that the presence of W alleles at the QTL on chromosome 4 ( Figure 1 ) was significantly and dominantly associated with a decrease in adenoma surface area, and was denominated rCcr1 for rat Colorectal carcinoma resistance. The presence of ACI alleles at the QTL on chromosome 15 was associated with average multiplicity values, for total lesions and PD adenocarcinomas, significantly lower that those of rats homozygous for W allele. An analogous behavior was found for PD adenocarcinoma multiplicity, for the QTL with suggestive LOD score values, on telomeric side of chromosome 15. We define these QTLs as rat rCcr2 and rCcr6, respectively. Rats bearing a W allele at the centromeric QTL on chromosome 18 showed lower PD adenocarcinoma multiplicity and surface area than rats homozygous for A allele. This QTL was tentatively named rat rCcr3. A second QTL on the chromosome 18 had a LOD score peak at 19.5 cM, suggestive of genetic linkage with PD adenocarcinoma multiplicity. A lower PD adenocarcinoma multiplicity occurred in rats bearing at least one W allele, suggesting the existence of a resistance gene and the locus was denominated rCcr8. Additional QTLs, in suggestive linkage with surface area or multiplicity of adenoma, and surface area of WD adenocarcinomas, on chromosomes 6, 17, and 20, were identified on the basis of the origin of the dominant allele and its phenotypic effects, as resistance loci and denominated rCcr4, rCcr5, rCcr7, and rCcr9 (Table 2) . Finally, a locus on chromosome 5 was classified as a susceptibility locus affecting adenoma surface area, and denominated rat Colorectal carcinoma resistance (rCcs) 1.
Interactions between loci
All QTLs identified, except rCcr2 whose R 2 value was around 58%, have R 2 values between 10.5% and 19.5% (Table 2) , indicating the presence of a main locus and several low penetrance genes predisposing to colorectal cancer. Since additive interactions may modify the phenotypic effects of QTLs, we evaluated the interactions between QTLs exhibiting analogous effects in relation to the allele distribution pattern in AWF2 rats for the markers closest to LOD score peaks. ANOVA showed significant variations among allelic combinations for the interactions between rCcr6
and rCcr3, rCcr6 and rCcr8, and rCcr5 and rCcr9 (P < 0.0001) (Figure 2) . Low values of PD adenocarcinoma multiplicity were found in rats bearing at least one A and W allele at markers D15Rat63, on chromosome 15, and D18Rat46, on chromosome 18, closest to the LOD score peaks of rCcr6 and rCcr3, respectively. The lowest values occurred in rats homozygous for the A allele at D15Rat63 and W allele at D18Rat46. In contrast, the inverse allelic association (WW at D15Rat63 and AA at D18Rat46) produced PD adenocarcinoma multiplicity values 1.9 to 24 times higher than all other combinations (1.2 ± 0.21 vs. 0.05 ± 0.001 to 0.62 ± 0.08; means ± SD, at least P < 0.01). An analogous situation was found for the interaction between rCcr6 and rCcr8. Relatively low PD adenocarcinoma multiplicity occurred in AWF2 rats homozygous or heterozygous for the A allele at marker D15Rat63 and for W allele at marker D18Rat57, whereas PD adenocarcinoma multiplicity of 1.1 ± 0.16, produced by the combination WW at D15Rat63 and AA at D18Rat57, was 3.1-27 times higher than all other combinations (at least P < 0.05). Finally, the presence of homozygous W allele at D6Rat101, and A allele at D20Rat13, closest to the LOD sore peaks of rCcr5 and rCcr9, respectively, was associated with adenoma multiplicity of 2.6 ± 0.53, significantly higher than the multiplicities at all other allelic combinations (at least P < 0.005). Analogous evaluation of the interactions between rCcr2 and rCcr6, rCcr3, or rCcr8, and rCcr1 and rCcr7 showed the absence of additive interactions.
Strong genetic interactions leading to synergistic effects in conferring cancer resistance (epistatic interactions) allowed identifying several tumor modifier loci in mouse and rat models of human cancer (29) (30) (31) . The evaluation of two-way interactions inducing phenotypic effects that were undetectable as the sum of single effects led to the identification of 4 novel loci with highly significant interactions: multiple comparisons showed significant increases in adenoma multiplicity, for the allelic combination WW/AA at D6Rat1 and D11Rat38 (P < 1.1 -7 ; corrected as in ref. 21 , P < 5.6 -6 ), and AA/WW at D1Rat165 and D6Rat101(P < 4 -5 ; corrected P < 2.1 -3 ), and significant increase in adenoma size for the allelic combination WW/AA at D1Rat86 and D10Rat25 (P < 7.3 -7 ; corrected P < 3.8 -5 ). Another locus affecting the multiplicity of WD and PD adenocarcinomas was detected by interaction between D13Rat11 and D18Rat57 for the allelic combination WW/AA (P < 7 -5 ; corrected P < 2.9 -3 ).
Wnt/β-catenin pathway
Among the putative candidate genes sited in the identified QTLs was Apc, located at rCcr3. Thus, we evaluated the eventual deregulation of Wnt/β-Catenin pathway by determining the subcellular localization of β-Catenin in colorectal lesions. β-Catenin immunostaining was located exclusively in cell membranes of normal colorectal mucosa of both ACI and WF rats (not shown). Evident interstrain differences in β-Catenin localization occurred in colorectal lesions ( Figure 3 ). In ACI rat lesions, diffuse cytoplasmic/nuclear β-Catenin positivity occurred only in one of 3 PD adenocarcinomas, with the other two PD adenocarcinomas and 3 of 4 WD adenocarcinomas exhibiting positivity in less than 50% of cells (C), and all adenomas (n = 5) showing exclusively membranous β-catenin immunoreactivity (A). A strikingly different β-Catenin pattern was detected in colorectal lesions from WF rats. Indeed, strong membranous, cytoplasmic and/or nuclear staining (affecting at least 50% of tumor cells) was found in 3 of 5 adenomas (B) and in all 19 WD adenocarcinomas (D) developed in these rats. In more advanced adenocarcinomas (E) and all 16 PD adenocarcinomas (F,G) of the same strain, strong cytoplasmic positivity was associated with β-Catenin nuclear translocation. In AWF1 rats, diffuse positivity only occurred in 9 of 13 PD adenocarcinomas, whereas adenomas (n = 10) and WD adenocarcinomas (n = 3) were negative. In agreement with these findings, the β-Catenin targets Axin2 and c-myc mRNA levels were 6 and 4 fold higher in WF CRCs than normal mucosa, respectively (P < 00.05), whereas moderate overexpression occurred in AWF1 and, at lower level, in ACI rats (Supplementary Figure 1) .
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The activation of Wnt/β-Catenin pathway was also assessed by immunoblot analysis after immunoprecipitation (Figure 4) . No interstrain differences in β-Catenin and Axin2 expression occurred in normal colon mucosa. β-Catenin increased in CRC of WF and ACI rats, whereas Axin2 was upregulated in all strains, with highest values in WF rats. Furthermore, the levels of phosphorylated β-Catenin (targeted for ubiquitination) were significantly more elevated in CRC of ACI rats than in WF corresponding lesions. The levels of the above described proteins in CRC from AWF1
were intermediate between those of WF and ACI strains. Figure 1) . These data were further confirmed by western blotting, which also excluded the presence of Apc truncating mutations in all tumor samples (not shown).
Discussion
Our results show that the resistance of ACI rats to CRC induction by DMH is associated with a low capacity of adenomas and WD adenocarcinomas to evolve to PD adenocarcinomas, whereas the high susceptibility of the WF strain rests on the rapid progression of adenomas to full malignancy. AWF1 rats exhibit an intermediate phenotype that suggests a global semi-dominant effect on the phenotypic trait of multiple A and W alleles and of the reciprocal interactions involved.
Genomic scanning of AWF2 intercrosses revealed three loci on chromosomes 4, 15, and 18, named rCcr1 to 3 on the basis of the phenotypic effects of the dominant allele, in significant linkage with the adenoma surface area, multiplicity of total lesions, or multiplicity and surface area of PD adenocarcinomas. Various other QTLs were in suggestive linkage with the phenotypic parameters. However, since their phenotypic effects were confirmed by ANOVA and some of them exhibited additive effects, these QTLs were not considered artifacts. We also discovered three epistatic interactions, affecting the multiplicity or size of adenomas, and a forth interaction affecting the multiplicity of WD and PD adenocarcinomas. Total variability explained by the association between the markers closest to the LOD score peaks and the character (R 2 ) was in the range of 10.5-19.5 for all QTLs except rCcr2, whose variability was ~58% indicating that this locus gives a major contribution to lesion multiplicity, sufficient to elicit per se a resistant phenotype (32) . All other CRC modifiers behaved as low-penetrance genes, but additive interaction of rCcr6 with rCcr3 and rCcr8, and of rCcr5 with rCcr9, produced phenotypic effects amounting between 23% and ~30%.
As already observed for the polygenic inheritance of tumors in other rodent tissues (31) , the linkage analysis of AWF2 rats indicates that some susceptibility alleles controlling colorectal carcinogenesis of AWF1 rats are contributed by the resistant strain. This observation suggests that the generation of the susceptible WF strain from a common presumably resistant feral ancestor (27) depends on the selective mutation of resistance alleles, with the production of allelic variants that are not activated by carcinogen treatment. The maintenance of unaltered resistance alleles in ACI rats inactivates susceptibility alleles that, however, may be active in a different genetic background, i.e. in subgroups of intercross rats. In the latter, . Our data deny its candidacy as a modifier gene in chemically induced CRC of rat, due to the absence of functional interstrain polymorphisms, and interstrain differences in Apc mRNA levels. Nonetheless, deregulation of the Wnt/β-Catenin pathway, as shown by diffuse nuclear/cytoplasmic localization of β-Catenin, occurred in almost all lesions of WF rats. In ACI and AWF1 rats only 33% and 69% of PD adenocarcinomas, respectively, exhibited diffuse nuclear/cytoplasmic β-Catenin immunostaining. Other adenocarcinomas showed β-Catenin immunostaining in less than 50% of cell, while adenomas of ACI and AWF1 rats were always negative. These observations link the deregulation of Wnt/β-Catenin pathway to the capacity of mucosal lesions to progress to CRC, taking into account the higher propensity of colorectal lesions of susceptible rats to evolve to more malignant stages. Indeed, β-Catenin accumulation in the cytoplasm and nuclei results in the activation of a number of genes, including growthrelated genes, such as c-myc, Cyclin D1, Cox2, Fra1 and Id2 (34) , and active growth is a prerequisite of tumor progression. APC mutation occurs in early stages of ∼60% of sporadic human CRC (35) . Different from the human disease, Wnt/β-Catenin pathway activation does not depend on both
Apc and β-Catenin mutations during CRC development in the rat strains investigated. Nonetheless, we provide evidence that susceptibility genes control this pathway by regulating β-Catenin phosphorylation (inactivation). This suggests that proteasomal degradation of phosphorylated β-Catenin is critical for the expression of a phenotype susceptible or resistant to CRC. Since a susceptible phenotype is characterized by the development of more advanced colorectal neoplastic lesions, the expression of phosphorylated β-Catenin may be a marker of CRC progression. The relationships of other components of the complex controlling β-Catenin phosphorylation (i.e. Axin1 and Gsk-3β) with polygenic predisposition in CRC are currently under investigation.
Other possible candidate modifiers or genes somehow influenced by modifiers are present in the loci discovered. rCcr1 harbors Nos3, overexpressed early during azoxymethane-induced CRC of rat (36) , and CDK5 upregulated in human CRC (37) . The PPAR-γ ligand ciglitazone induces CDK5 downregulation and inhibits in vitro proliferation of HT-29 colon PD adenocarcinoma cells (37) . Other genes located at rCcr1, include CD36, Il6, and HGF. CD36 polymorphism, interacting with moderate-high meat consumptions (38) , and Il6 polymorphism are associated with increased CRC risk (39) . Molecular co-expression of c-MET and HGF correlates with a metastatic phenotype of human CRC (40) . rCcr4
harbors Odc, and rCcr9 harbors S-adenosylmethionine decarboxylase, two genes encoding key enzymes in polyamine synthesis. These genes are upregulated in human CRC and ODC gene polymorphisms represent a genetic marker for sporadic human CRC risk (41) . N-myc, located at rCcr4 Other genes involved in colorectal carcinogenesis, located in the discovered QTLs, include EGR1 (45) and FGF1 (46), at rCcr3, and CtsL (cathepsin L) at rCcr7 (47). The deregulation in human CRC of several genes located at rat QTLs suggests the commonalty of some genetic mechanisms in rodent and human colorectal carcinogenesis. Moreover, rat chromosomal segments where rCcr1, rCcr3, rCcr4, and rCcr7 are located, are syntenic to human microsatellite loci at 5q21, 18q11-q12, 2p16, 5q12, and 3p21, frequent sites of allelic imbalance in CRCs and, less frequently, in ACFs (48). The human 15q21.1 sub-band, syntenic to rCcr6, harbors a putative oncosuppressor gene (49), suggesting a possible location of QTLs related to CRC in the human genome. This hypothesis is reinforced by the location of mouse Ccs1 and Scc5 loci on chromosomes 12 and 18, respectively, at sites syntenic to rat rCcr4 and rCcr3, suggesting the existence of some interspecies correspondences in the genetic predisposition to CRC. However, the modifier of mouse intestinal tumorigenesis, Ptprj gene located at Scc1, maps to chromosome 3 of rat, where no known QTLs were found. In accordance with previous observations (2, 5) , the present results strongly support the idea that rat models of colorectal carcinogenesis, despite the different etiology from that of human CRC, mimic some phenotypic and molecular features controlling the development and progression of human preneoplastic and neoplastic colorectal lesions.
Overall, we identified three novel loci, in significant linkage with chemically induced CRC of rat, and three epistatic loci controlling the progression of early benign lesions to full malignancy. The existence of a locus with relatively high phenotypic effect, and various additive and epistatic genetic interactions, envisages a complex genetic model, controlling sporadic colorectal carcinogenesis, with various low penetrance genes and a main gene. Furthermore, we demonstrated the influence of susceptibility genes on the Wnt/β-Catenin signaling. The transition from locus to gene is a complex and long-term task (50). Future development of the present research include narrowing of the QTL regions, by the production of congenic rat strains and gene cloning, to better define candidate modifier genes and discover eventual interstrain polymorphisms consistent with interstrain differences in phenotypic behavior. This will allow identifying these genes as modifiers or targets of modifiers, whose role must be evaluated in human colorectal carcinogenesis. The identification of the molecular mechanisms affected by predisposition genes can further clarify the pathogenesis of human CRC. a Twenty rats per each strain were treated with DMH (20 mg/kg b. wt., weekly) for 26 weeks and were killed 32 week after treatment initiation.
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